Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Samuels, Amy L ^a,b   Peeva, Violet K ^a   Papa, Rachael A ^c   Firth, Marin J ^a,b   Francis, Richard W ^a   Beesley, Alex H ^a,b   Lock, Richard B ^c   Kees, Ursula R ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CROSS HYBRIDIZATION; DISEASE COURSE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MASKING; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; REPRODUCIBILITY; SCID MOUSE; SPECIES DIFFERENCE; TUMOR ENGRAFTMENT; TUMOR MODEL; TUMOR XENOGRAFT; VALIDATION PROCESS; ANIMAL; BONE MARROW; CANCER TRANSPLANTATION; DISEASE MODEL; GENETICS; METABOLISM; MOUSE MUTANT; SPLEEN;

ANIMALS; BONE MARROW; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SPECIES SPECIFICITY; SPLEEN;

EID: 77951062112     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-256     Document Type: Article

References (33)

1. Macor P, Secco E, Zorzet S, Tripodo C, Celeghini C, Tedesco F. An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies. Current Pharmaceutical Design 2008, 14(21):2023-2039. 10.2174/138161208785294591, 18691113.
2. Lock RB, Liem N, Farnsworth ML, Milross CG, Xue C, Tajbakhsh M, Haber M, Norris MD, Marshall GM, Rice AM. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 2002, 99(11):4100-4108. 10.1182/blood.V99.11.4100, 12010813.
3. Kamel-Reid S, Letarte M, Sirard C, Doedens M, Grunberger T, Fulop G, Freedman MH, Phillips RA, Dick JE. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science 1989, 246(4937):1597-1600. 10.1126/science.2595371, 2595371.
4. Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JH. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice. Exp Hematol 2001, 29(3):322-329. 10.1016/S0301-472X(00)00669-X, 11274760.
5. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008, 371(9617):1030-1043. 10.1016/S0140-6736(08)60457-2, 18358930.
6. Kamb A. What's wrong with our cancer models?. Nat Rev Drug Discov 2005, 4(2):161-165. 10.1038/nrd1635, 15688078.
7. Baersch G, Mollers T, Hotte A, Dockhorn-Dworniczak B, Rube C, Ritter J, Jurgens H, Vormoor J. Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr 1997, 209(4):178-185. 10.1055/s-2008-1043947, 9293448.
8. Borgmann A, Baldy C, von Stackelberg A, Beyermann B, Fichtner I, Nurnberg P, Henze G. Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol 2000, 17(8):635-650. 10.1080/08880010050211349, 11127395.
9. Dialynas DP, Shao L, Billman GF, Yu J. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood. Stem Cells 2001, 19(5):443-452. 10.1634/stemcells.19-5-443, 11553853.
10. Liem NL, Papa RA, Milross CG, Schmid MA, Tajbakhsh M, Choi S, Ramirez CD, Rice AM, Haber M, Norris MD, et al. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies. Blood 2004, 103(10):3905-3914. 10.1182/blood-2003-08-2911, 14764536.
11. Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C, Gorlick R, Kolb EA, Zhang W, Lock R, et al. The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer 2007, 49(7):928-940. 10.1002/pbc.21078, 17066459.
12. Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, et al. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res 2008, 14(14):4572-4583. 10.1158/1078-0432.CCR-07-5090, 18628472.
13. Peterson JK, Houghton PJ. Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development. Eur J Cancer 2004, 40(6):837-844. 10.1016/j.ejca.2004.01.003, 15120039.
14. Whiteford CC, Bilke S, Greer BT, Chen Q, Braunschweig TA, Cenacchi N, Wei JS, Smith MA, Houghton P, Morton C, et al. Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis. Cancer Res 2007, 67(1):32-40. 10.1158/0008-5472.CAN-06-0610, 17210681.
15. Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Br J Haematol 2005, 131(4):447-456. 10.1111/j.1365-2141.2005.05785.x, 16281934.
16. Hoffmann K, Firth MJ, Beesley AH, de Klerk NH, Kees UR. Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer 2006, 6:229. 10.1186/1471-2407-6-229, 1609180, 17002788.
17. Gottardo NG, Hoffmann K, Beesley AH, Freitas JR, Firth MJ, Perera KU, de Klerk NH, Baker DL, Kees UR. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 2007, 137(4):319-328. 10.1111/j.1365-2141.2007.06576.x, 17456054.
18. Hoffmann K, Firth MJ, Beesley AH, Freitas JR, Ford J, Senanayake S, de Klerk NH, Baker DL, Kees UR. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index. Br J Haematol 2008, 140(6):656-664. 10.1111/j.1365-2141.2008.06981.x, 18302714.
19. Beesley AH, Firth MJ, Ford J, Weller RE, Freitas JR, Perera KU, Kees UR. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism. Br J Cancer 2009, 100(12):1926-1936. 10.1038/sj.bjc.6605072, 19436302.
20. Boag JM, Beesley AH, Firth MJ, Freitas JR, Ford J, Hoffmann K, Cummings AJ, de Klerk NH, Kees UR. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia. Leukemia 2006, 20(10):1731-1737. 10.1038/sj.leu.2404365, 17041637.
21. Boag JM, Beesley AH, Firth MJ, Freitas JR, Ford J, Brigstock DR, de Klerk NH, Kees UR. High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia. Br J Haematol 2007, 138(6):740-748. 10.1111/j.1365-2141.2007.06739.x, 17760805.
22. Creighton C, Kuick R, Misek DE, Rickman DS, Brichory FM, Rouillard JM, Omenn GS, Hanash S. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol 2003, 4(7):R46. 10.1186/gb-2003-4-7-r46, 193633, 12844362.
23. Creighton CJ, Bromberg-White JL, Misek DE, Monsma DJ, Brichory F, Kuick R, Giordano TJ, Gao W, Omenn GS, Webb CP, et al. Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res 2005, 3(3):119-129. 10.1158/1541-7786.MCR-04-0189, 15798092.
24. Harrell JC, Dye WW, Harvell DM, Sartorius CA, Horwitz KB. Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases. Clin Exp Metastasis 2008, 25(1):81-88. 10.1007/s10585-007-9105-7, 17932773.
25. Naef F, Huelsken J. Cell-type-specific transcriptomics in chimeric models using transcriptome-based masks. Nucleic Acids Res 2005, 33(13):e111. 10.1093/nar/gni104, 1178007, 16030348.
26. Wilson CL, Sims AH, Howell A, Miller CJ, Clarke RB. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer 2006, 13(2):617-628. 10.1677/erc.1.01165, 16728587.
27. Smyth GK. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Statistical Applications in Genetics and Molecular Biology 2004, 3(1). 10.2202/1544-6115.1027, 16646809.
28. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57(1):289-300.
29. Ihaka R, Gentleman R. R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics 1996, 5(3):299-314.
30. Team RDC R: A language and environment for statistical computing. 2008, R Foundation for Statistical Computing. Vienna, Austria, Team RDC.
31. Ensembl website. , http://www.ensembl.org/index.html
32. Affymetrix website. , http://www.affymetrix.com/index.affx
33. Blat parameters. , http://genome.ucsc.edu/FAQ/FAQblat#blat8